More about

Biologic

News
September 16, 2024
1 min read
Save

Bone marrow aspirate concentrate may not benefit patients undergoing meniscectomy

Bone marrow aspirate concentrate may not benefit patients undergoing meniscectomy

Published results showed autologous bone marrow aspirate concentrate injections may not provide benefit as an adjuvant for patients with meniscal tears and concomitant knee osteoarthritis who undergo arthroscopic partial meniscectomy.

News
September 13, 2024
6 min read
Save

Depemokimab reduces severe asthma exacerbations by half with twice-yearly treatment

Depemokimab reduces severe asthma exacerbations by half with twice-yearly treatment

Patients with severe eosinophilic asthma who used depemokimab administered every 6 months experienced a 54% reduction in exacerbations over 52 weeks, according to a study presented at the European Respiratory Society International Congress.

News
September 13, 2024
6 min read
Save

Response to biologics for asthma varies by outcome

Response to biologics for asthma varies by outcome

Patients with greater impairment before initiating biologic treatment for asthma had better response across all assessed outcomes, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
August 23, 2024
6 min read
Save

Options available for patients with urticaria whose omalizumab therapy fails

Options available for patients with urticaria whose omalizumab therapy fails

SAN ANTONIO — Patients with urticaria who do not respond to omalizumab have other options for treatment, David A. Khan, MD, said during the 16th Annual Allergy, Asthma & Immunology CME Conference.

News
August 21, 2024
2 min read
Save

Adoption of ophthalmic biosimilars expected to remain slow

Adoption of ophthalmic biosimilars expected to remain slow

Most of us are familiar with the different classes of eye drops.

News
August 15, 2024
3 min read
Save

Q&A: Prior authorization limits, delays options in allergy, asthma care

Q&A: Prior authorization limits, delays options in allergy, asthma care

Prior authorization remains a challenge for many practices despite recent changes in regulations, with obstacles specific to asthma, allergy and immunology care.

News
August 13, 2024
2 min read
Save

Patients, clinicians support use of as-needed biologic therapy for psoriasis

Patients, clinicians support use of as-needed biologic therapy for psoriasis

Patients and clinicians agree that as-needed use of biologic therapy has benefits over continuous long-term biologic use for the treatment of psoriasis, according to a study.

News
August 12, 2024
5 min read
Save

Personalized care can help patients adhere to biologic treatment for asthma

Personalized care can help patients adhere to biologic treatment for asthma

SAN ANTONIO — Personalized treatment strategies can help providers overcome barriers to biologic care for patients with asthma, Lukena Karkhanis, MD, said at the 16th Annual Allergy, Asthma & Immunology CME Conference.

News
June 21, 2024
3 min read
Save

Q&A: How to use ‘buy and bill’ for biologic treatment in allergy, asthma care

Q&A: How to use ‘buy and bill’ for biologic treatment in allergy, asthma care

As biologics become more popular for a growing number of indications, practices need to figure out the most cost-effective ways to provide these treatments to their patients.

Clinical Guidance
Food Allergy
Treatment and Management

Food Allergy Management

Douglas H. Jones, MD, FAAAAI, FACAAI

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

View more